Editorial & Advertiser disclosure

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Home > Finance > Smith & Nephew shares drop 9% as US knee implant sales lag

Finance

Smith & Nephew shares drop 9% as US knee implant sales lag

Published by Global Banking and Finance Review

Posted on November 6, 2025

Featured image for article about Finance

(Reuters) -Shares of Smith & Nephew fell nearly 9% on Thursday after the British medical products maker missed analyst estimates for quarterly revenue due to weakness in its U.S. knee implants business.

The company reported quarterly revenue of $1.50 billion as compared to estimates of $1.51 billion, according to a company compiled poll.

(Reporting by Rishab Shaju in Bengaluru; Editing by Mrigank Dhaniwala)

More from Finance

Explore more articles in the Finance category

Mercedes brings forward €5 billion fixed cost reduction target to end-2026 - Manager Magazin

China says it is granting new, streamlined rare earth export licences

Romania to raise minimum wage by 6.8% from July

UK electricals retailer Currys says well placed for Christmas

Coinbase appoints UK ex-finance minister George Osborne to run advisory council

EU must reform or risk irrelevance, Blair and Dimon say

Europe's auto industry future may be electric even after EU climbdown

Factbox-Can Ukraine survive without the EU's 'reparation loan'?

EU leaders face crunch decision on using frozen Russian assets for Ukraine

Analysis-Return of 'Make Europe Great Again' trades hinges on German comeback

Boeing, union pause contract talks for former Spirit AeroSystems engineers

ECB to hold rates steady as euro zone economy shows resilience

View All Finance Posts